• No results found

The biology of cognitive decline and reduced survival in Parkinson disease

N/A
N/A
Protected

Academic year: 2021

Share "The biology of cognitive decline and reduced survival in Parkinson disease"

Copied!
2
0
0

Loading.... (view fulltext now)

Full text

(1)

The biology of cognitive decline and reduced survival in Parkinson disease

Prognostic factors in a population-based cohort

David Bäckström

(2)

ISBN: 978-91-7855-022-7 ISSN: 0346-6612 Department of Pharmacology and Clinical Neuroscience

Umeå University, SE-901 87 Umeå www.umu.se

ISBN 978-91-7855-022-7 ISSN 0346-6612

References

Related documents

Keywords: coronary heart disease, acute coronary syndrome, coronary-bypass grafting, mor- tality, case fatality, survival, manifestation, predictors, risk factors,

After adjustment for age, a diagnosis of mild cognitive impairment, a PIGD phenotype, high disease severity (as measured by total- and part III UPDRS scores), general slowness (as

Parkinson disease, multiple system atrophy, progressive supranuclear palsy, natural history, cognitive impairment, dementia, predictors of mortality, cerebrospinal fluid

Cumulative survival for patients with a baseline cNfL below the median concentration of 903 ng/L (blue line) compared with those with cNfL above 903 ng/L (red line) in the (B)

PD, Parkinson’s disease; COMT, catechol- O- methyltransferase; DRD2, dopamine receptor D2; MCI, mild cognitive impairment; PDD, Parkinson’s disease dementia... 96  |  

A neurobiological factor (biomarker) that predicted a shorter survival in PD was reduced DAT uptake in the striatum, particularly in the caudate nucleus (1.48 times higher hazard

Subjecti ve cogniti ve decline in memory clinic patients – c har acteristics and clinical rele vance | Marie Ec kerström.

In Study IV we investigated the moderating effects of birth cohort on the associations between cardiovascular risk (defined as the Framingham Risk Score, FRS) and cognitive